Northwestern Mutual Wealth Management CO Biotechnology

Northwestern Mutual Wealth Management CO

$112 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AMRN Amarin Corp Plcuk	$222M	$3,000 0.0% of portfolio	5,000	Q2 2024 Reduced 5.48%
FOLD Amicus Therapeutics, Inc.	$2.74B	$3,000 0.0% of portfolio	350	Q2 2023 New
CORT Corcept Therapeutics Inc	$7.17B	$3,000 0.0% of portfolio	72	Q3 2024 New
ORMP Oramed Pharmaceuticals Inc.	$83.9M	$3,000 0.0% of portfolio	1,575	Q3 2022 New
RVMD Revolution Medicines, Inc.	$3.71B	$3,000 0.0% of portfolio	69	Q3 2024 New
VIRI Virios Therapeutics, Inc.	$81.4M	$3,000 0.0% of portfolio	19,062	Q1 2024 New
ALLO Allogene Therapeutics, Inc.	$233M	$2,000 0.0% of portfolio	1,000	Q3 2021 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.33B	$2,000 0.0% of portfolio	133	Q3 2024 New
CGTX Cognition Therapeutics Inc	$14.3M	$2,000 0.0% of portfolio	5,867	Q4 2022 New
IMUX Immunic, Inc.	$29.3M	$2,000 0.0% of portfolio	1,500	Q1 2024 New
TSVT 2seventy Bio, Inc.	$98.1M	$1,000 0.0% of portfolio	276	Q3 2024 Added 375.86%
AKRO Akero Therapeutics, Inc.	$2.5B	$1,000 0.0% of portfolio	35	Q3 2024 New
ARCT Arcturus Therapeutics Holdings Inc.	$420M	$1,000 0.0% of portfolio	58	Q3 2024 New
ARMP Armata Pharmaceuticals, Inc.	$72.3M	$1,000 0.0% of portfolio	571	Q2 2019 New
RNA Avidity Biosciences, Inc.	$1.67B	$1,000 0.0% of portfolio	40	Q3 2024 New
CUE Cue Biopharma, Inc.	$52.4M	$1,000 0.0% of portfolio	2,500	Q3 2024 Added 400.0%
IMNM Immunome Inc.	$133M	$1,000 0.0% of portfolio	100	Q3 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$304M	$1,000 0.0% of portfolio	300	Q3 2021 New
SANA Sana Biotechnology, Inc.	$582M	$1,000 0.0% of portfolio	244	Q3 2024 Added 22.0%
STOK Stoke Therapeutics, Inc.	$454M	$1,000 0.0% of portfolio	119	Q3 2024 New
RARE Ultragenyx Pharmaceutical Inc.	$3.09B	$1,000 0.0% of portfolio	22	Q3 2024 New
VKTX Viking Therapeutics, Inc.	$2.42B	$1,000 0.0% of portfolio	28	Q3 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$192M	$0 0.0% of portfolio	67	Q3 2024 Added 6,600.0%
ACAD Acadia Pharmaceuticals Inc	$3.03B	$0 0.0% of portfolio	20	Q3 2024 New
ATNM Actinium Pharmaceuticals, Inc.	$30.2M	$0 0.0% of portfolio	107	Q3 2020 New
ADAP Adaptimmune Therapeutics PLC	$96.4M	$0 0.0% of portfolio	69	Q3 2024 New
ADPT Adaptive Biotechnologies Corp	$1.1B	$0 0.0% of portfolio	24	Q3 2024 New
ADCT Adc Therapeutics Sa	$123M	$0 0.0% of portfolio	36	Q3 2024 New
AIM Aim Immuno Tech Inc.	$8.65M	$0 0.0% of portfolio	600	Q3 2024 New
ALEC Alector, Inc.	$135M	$0 0.0% of portfolio	50	Q3 2024 New
ALT Altimmune, Inc.	$316M	$0 0.0% of portfolio	100	Q1 2019 New
RCUS Arcus Biosciences, Inc.	$968M	$0 0.0% of portfolio	1	Q3 2021 Reduced 99.96%
BEAM Beam Therapeutics Inc.	$1.81B	$0 0.0% of portfolio	24	Q3 2024 New
BNOX Bionomics Limited	$24.4M	$0 0.0% of portfolio	303	Q3 2024 New
BTAI Bio Xcel Therapeutics, Inc.	$8.69M	$0 0.0% of portfolio	340	Q3 2024 Reduced 3.68%
BDTX Black Diamond Therapeutics, Inc.	$90.8M	$0 0.0% of portfolio	35	Q3 2024 New
BLUE Bluebird Bio, Inc.	$542M	$0 0.0% of portfolio	680	Q3 2024 Added 288.57%
BCLI Brainstorm Cell Therapeutics Inc.	$69.3M	$0 0.0% of portfolio	161	Q2 2024 New
CABA Cabaletta Bio, Inc.	$67M	$0 0.0% of portfolio	93	Q3 2024 New
CAPR Capricor Therapeutics, Inc.	$371M	$0 0.0% of portfolio	19	Q2 2024 New
CARA Cara Therapeutics, Inc.	$257M	$0 0.0% of portfolio	2,020	Q3 2024 New
CRDF Cardiff Oncology, Inc.	$184M	$0 0.0% of portfolio	48	Q2 2020 New
SAVA Cassava Sciences Inc	$94.6M	$0 0.0% of portfolio	12	Q3 2024 New
CDXS Codexis, Inc.	$280M	$0 0.0% of portfolio	1	Q2 2024 Reduced 83.33%
EDIT Editas Medicine, Inc.	$87.3M	$0 0.0% of portfolio	61	Q3 2024 Added 6,000.0%
FATE Fate Therapeutics Inc	$127M	$0 0.0% of portfolio	255	Q2 2024 Reduced 70.18%
GOSS Gossamer Bio, Inc.	$96.8M	$0 0.0% of portfolio	261	Q3 2024 New
GRTS Gritstone Bio, Inc.	$2.19M	$0 0.0% of portfolio	100	Q3 2024 New
HRTX Heron Therapeutics, Inc.	$201M	$0 0.0% of portfolio	53	Q3 2024 New
LEXX Lexaria Bioscience Corp.	$10.5M	$0 0.0% of portfolio	9	Q3 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.